Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

IBT-V02: Staphylococcus aureus vaccine that confers protection in mouse and rabbit

July 3, 2020

Phase III trial of Kevzara in COVID-19 does not meet primary and key secondary endpoints

July 3, 2020

Spanish approval granted for COVID-19 study using EnteraGam

July 3, 2020

Janssen synthesizes new cyclopentyl nucleoside analogues

July 3, 2020

Meissa completes pre-IND meeting for COVID-19 vaccine candidate MV-014-210

July 3, 2020

Programmed necrosis has role in post-flu bacterial infections

July 3, 2020

Recruitment starts in phase II study of DUR-928 in COVID-19 with acute liver or kidney injury

July 2, 2020

Early positive data for BNT-162b1 vaccine candidate against SARS-CoV-2

July 2, 2020

FDA approves IND for phase II study of antroquinonol in patients with COVID-19

July 2, 2020

Hoth enters sponsored research agreement with VCU for potential peptide COVID-19 therapeutic

July 1, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...